One of the biggest challenges with running a Phase IV study is the cost which can in many cases be prohibitive particularly for a market like the UK.
uMed Research provides a solution which enable Life Sciences companies to run Phase IV observational studies in a cost effective and timely way.
Our process is the following:
- Identify patients from their EHR record with inclusion/exclusion criteria to create an ideal cohort
- Reach out to these patients via our GP network to consent and enrol them into the study
- Collect patient report outcome data remotely
- Integrate the data collected with the patient’s EHR record
In this way, we can quickly enrol a large number of patients into a study and scale the tracking of the patient reported outcomes in a cost effective way using our software platform/technology.
Whether it be building matched control arms to support your active monitoring study, demonstrating the effectiveness of Software as a Medical Device or making the case for changing the standard of care for your product area we can help you to quickly build evidence.
Please get in touch to find out more.